Zimmer Biomet (ZBH) Raises EPS Outlook on Robotics Gains Is Its Transformation Story Taking Shape?

Simply Wall St.

Jun 28

Earlier this week, Zimmer Biomet Holdings reaffirmed its 1–3% revenue growth guidance and raised its earnings-per-share outlook, citing early benefits from its commercial transformation and robotics ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2646197183"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2646197183\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2646197183?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2026-06-28 06:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2646197183","market":"us","top_or_hot":-1,"title":"Zimmer Biomet (ZBH) Raises EPS Outlook on Robotics Gains Is Its Transformation Story Taking Shape?","media":"Simply Wall St.","content":"<div>\n<p>Earlier this week, Zimmer Biomet Holdings reaffirmed its 1–3% revenue growth guidance and raised its earnings-per-share outlook, citing early benefits from its commercial transformation and robotics ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-zbh/zimmer-biomet-holdings/news/zimmer-biomet-zbh-raises-eps-outlook-on-robotics-gains-is-it\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zimmer Biomet (ZBH) Raises EPS Outlook on Robotics Gains Is Its Transformation Story Taking Shape?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZimmer Biomet (ZBH) Raises EPS Outlook on Robotics Gains Is Its Transformation Story Taking Shape?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-28 06:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-zbh/zimmer-biomet-holdings/news/zimmer-biomet-zbh-raises-eps-outlook-on-robotics-gains-is-it><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Earlier this week, Zimmer Biomet Holdings reaffirmed its 1–3% revenue growth guidance and raised its earnings-per-share outlook, citing early benefits from its commercial transformation and robotics ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-zbh/zimmer-biomet-holdings/news/zimmer-biomet-zbh-raises-eps-outlook-on-robotics-gains-is-it\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ZBH","symbol_name":"齐默巴奥米特控股","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-zbh/zimmer-biomet-holdings/news/zimmer-biomet-zbh-raises-eps-outlook-on-robotics-gains-is-it","article_id":"2646197183","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-zbh/zimmer-biomet-holdings/news/zimmer-biomet-zbh-raises-eps-outlook-on-robotics-gains-is-it","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2646197183","pubTimestamp":1782598736,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Earlier this week, Zimmer Biomet Holdings reaffirmed its 1–3% revenue growth guidance and raised its earnings-per-share outlook, citing early benefits from its commercial transformation and robotics investments.\nThe update suggests Zimmer Biomet’s push into AI-enabled robotics and a more efficient commercial model is beginning to translate into stronger profitability expectations.\nWe’ll now examine how the raised EPS outlook, underpinned by robotics momentum, may influence Zimmer Biomet’s...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ZBH":"齐默巴奥米特控股","ROBO":"全球机器人自动化ETF-ROBO","BOTZ":"Global X Robotics & Artificial Intelligence ETF"},"translate_title":"Zimmer Biomet(ZBH)上调机器人技术收益每股收益预期其转型故事正在形成吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BOTZ":1.5,"ZBH":1.5,"ROBO":1.5},"content_text":"Earlier this week, Zimmer Biomet Holdings reaffirmed its 1–3% revenue growth guidance and raised its earnings-per-share outlook, citing early benefits from its commercial transformation and robotics investments. The update suggests Zimmer Biomet’s push into AI-enabled robotics and a more efficient commercial model is beginning to translate into stronger profitability expectations. We’ll now examine how the raised EPS outlook, underpinned by robotics momentum, may influence Zimmer Biomet’s existing investment narrative. Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 29 best rare earth metal stocks of the very few that mine this essential strategic resource.AdvertisementZimmer Biomet Holdings Investment Narrative RecapTo own Zimmer Biomet, you need to believe its focus on orthopedic implants, robotics and digital surgery can compound value even with modest top line growth. The reaffirmed 1–3% revenue guidance and higher EPS outlook point to cost discipline and robotics leverage as the key near term catalyst, while competitive pressure in AI driven robotics and core orthopedics remains the most pressing risk. The latest update does not materially change that risk, but it does reinforce earnings execution as the central story. Among recent announcements, the ongoing launch and expansion of the ROSA and Z1 robotics platforms, alongside AI enabled tools like OrthoGrid Hip AI, ties directly into the improved earnings outlook. These systems are central to Zimmer Biomet’s push toward higher margin, premium procedures and could be an important driver behind management’s growing confidence in profitability. How well these platforms gain share in a crowded robotics market will be crucial for the current thesis. Yet while early robotics momentum supports the earnings story, investors should also be aware of the growing competitive intensity in AI enabled surgical systems and... Read the full narrative on Zimmer Biomet Holdings (it's free!)Zimmer Biomet Holdings’ narrative projects $9.2 billion revenue and $1.2 billion earnings by 2029.Uncover how Zimmer Biomet Holdings' forecasts yield a $98.70 fair value, a 6% upside to its current price.Exploring Other PerspectivesZBH 1-Year Stock Price Chart Four members of the Simply Wall St Community currently see Zimmer Biomet’s fair value between US$98.70 and about US$209.98, reflecting very different expectations. Set against management’s raised EPS outlook tied to robotics investments, this spread underlines how differently people are weighing the promise of premium surgical platforms against execution and competitive risks, so it is worth comparing several viewpoints before forming your own.Explore 4 other fair value estimates on Zimmer Biomet Holdings - why the stock might be worth just $98.70!Reach Your Own ConclusionDon't just follow the ticker - dig into the data and build a conviction that's truly your own.A great starting point for your Zimmer Biomet Holdings research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.Our free Zimmer Biomet Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Zimmer Biomet Holdings' overall financial health at a glance.Interested In Other Possibilities?Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 15 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.We've uncovered the 8 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Zimmer Biomet Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}